AifaBot is a venture platform investing in Artificial Intelligence and Life Sciences. We back founders, incubate breakthrough companies, and bridge North America and Asia, uniting talent, capital, industry and supply chains across the Pacific.
The defining companies of the next decade will be built at the intersection of AI and the life sciences, and scaled across more than one continent. We exist to make that journey shorter, smarter and better capitalised.
We concentrate where scientific depth and computational power compound each other, where a single platform can redefine an industry.
Foundational and applied AI that turns data into decisions, from enabling infrastructure to vertical intelligence for the world’s largest industries.
Science-led companies extending and improving human life: from discovery to the clinic, from the lab bench to the patient’s home.
Computational biology, intelligent diagnostics and autonomous labs sit at the overlap of both sectors: the space where we believe the largest value will be created.
We combine capital with company-building and a cross-border network, so founders receive far more than a cheque.
Seed to growth-stage capital for exceptional teams in AI and life sciences, with co-investment from a curated syndicate of partners.
Hands-on venture building from university labs and spin-outs: strategy, governance, regulatory pathway and first customers.
A living bridge between North America and Asia: introductions to investors, corporates, hospitals, research institutes and governments.
Market entry, manufacturing partners and supply-chain access to take products from prototype to global commercialisation.
North America leads in frontier science and venture depth. Asia leads in manufacturing scale, speed and market reach. We assemble both into a single, founder-ready platform.
Pharma and technology leaders, academic medical centres and early-adopter enterprises for pilots and validation.
Industrial groups, hospital networks and fast-moving markets ready to deploy and scale proven solutions.
Deep venture and angel networks, non-dilutive research funding, and a clear path to public markets.
Strategic corporate investors, family offices, government-guided funds and industry-specific capital.
Regulatory expertise, quality systems and specialised contract research for clinical-grade development.
Deep manufacturing, hardware and electronics ecosystems, CDMO capacity and cost-efficient scale-up.
Leading universities and research institutes, frontier IP and a deep pool of scientific and technical founders.
A vast engineering workforce, rapidly growing R&D investment and experienced commercial operators.
Navigation of FDA and Health Canada pathways, reimbursement models and enterprise procurement.
Market entry, local partnerships, policy incentives and innovation-park programmes across the region.
Discover in North America. Build and scale with Asia. Grow on both sides of the Pacific, through one trusted partner.
Headquartered in Vancouver, Canada’s Pacific gateway, we operate as a two-way channel for founders, investors and industry partners.
